O'Neill Gilmore Neil — SEC insider filings

SEC reporting owner CIK 1742084. 27 insider filings on record with FilingPulse; latest filed 2026-11-13.

Transaction summary — filings shown

Covers all 27 filings on record, filed 2020-12-14 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Editas Medicine, Inc. (EDIT)CEO, Director18—13 legs · 189,755 sh · $1,070,55612
Unity Biotechnology, Inc. (UBX)Director5——5
Sarepta Therapeutics, Inc. (SRPT)EVP, R&D & CMO2——4
Aptinyx Inc. (APTX)Director2——2

Insider filings — O'Neill Gilmore Neil

FiledFormIssuerReported transactionsSource
2026-11-134Editas Medicine, Inc. (EDIT)Sale (S): 21,164 @ $2.42EDGAR
2026-11-064Editas Medicine, Inc. (EDIT)Grant/award (A): 43,567 @ $0EDGAR
2026-09-044Editas Medicine, Inc. (EDIT)Sale (S): 5,124 @ $3.04EDGAR
2026-06-054Editas Medicine, Inc. (EDIT)Sale (S): 15,380 @ $2.70EDGAR
2026-03-164Editas Medicine, Inc. (EDIT)Grant/award (A): 1,015,200 (derivative) @ $0EDGAR
2026-03-044Editas Medicine, Inc. (EDIT)Sale (S): 5,394 @ $2.02EDGAR
2025-12-044Editas Medicine, Inc. (EDIT)Sale (S): 5,603 @ $2.15EDGAR
2025-09-044Editas Medicine, Inc. (EDIT)Sale (S): 5,592 @ $2.60EDGAR
2025-06-044Editas Medicine, Inc. (EDIT)Sale (S): 15,192 @ $1.72EDGAR
2025-03-274Editas Medicine, Inc. (EDIT)Grant/award (A): 828,000 (derivative) @ $0 · Grant/award (A): 175,000 (derivative) @ $0EDGAR
2025-03-054Editas Medicine, Inc. (EDIT)Sale (S): 16,632 @ $1.71EDGAR
2024-12-054Editas Medicine, Inc. (EDIT)Sale (S): 1,618 @ $2.08EDGAR
2024-09-064Editas Medicine, Inc. (EDIT)Sale (S): 1,555 @ $3.42EDGAR
2024-06-214Unity Biotechnology, Inc. (UBX)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2024-06-064Editas Medicine, Inc. (EDIT)Sale (S): 12,191 @ $5.50EDGAR
2024-03-054Editas Medicine, Inc. (EDIT)Grant/award (A): 130,700 @ $0 · Grant/award (A): 72,213 @ $0 · Grant/award (A): 72,212 @ $0 · Sale (S): 77,824 @ $9.42 · Grant/award (A): 392,100 (derivative) @ $0EDGAR
2023-06-264Unity Biotechnology, Inc. (UBX)Grant/award (A): 6,000 (derivative) @ $0EDGAR
2023-06-074Editas Medicine, Inc. (EDIT)Sale (S): 6,486 @ $9.50EDGAR
2023-03-064Editas Medicine, Inc. (EDIT)Grant/award (A): 50,000 @ $0 · Grant/award (A): 150,000 (derivative) @ $0EDGAR
2022-06-274Unity Biotechnology, Inc. (UBX)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2022-06-064Editas Medicine, Inc. (EDIT)Grant/award (A): 86,655 @ $0 · Grant/award (A): 950,209 (derivative) @ $0EDGAR
2022-05-314Aptinyx Inc. (APTX)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2021-10-224Aptinyx Inc. (APTX)Grant/award (A): 80,000 (derivative) @ $0EDGAR
2021-06-284Unity Biotechnology, Inc. (UBX)Grant/award (A): 13,425 (derivative) @ $0EDGAR
2021-03-104/ASarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 524 @ $86.97 · Grant/award (A): 15,000 @ $0EDGAR
2021-03-054Sarepta Therapeutics, Inc. (SRPT)Grant/award (A): 15,000 @ $0 · Grant/award (A): 60,000 (derivative) @ $0EDGAR
2020-12-144Unity Biotechnology, Inc. (UBX)Grant/award (A): 50,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1742084 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs